Bipolar II disorder is one of the most frequently misdiagnosed conditions in psychiatry — most often misidentified as unipolar major depression, sometimes for years or decades. The distinction matters enormously because treatment is different: antidepressants given to someone with undiagnosed Bipolar II can trigger hypomania or rapid cycling and worsen the illness long-term.
Hypomania is a distinct mood episode of elevated, expansive, or irritable mood lasting at least 4 days, that represents a clear change from baseline and is observable to others. Unlike full mania, hypomania does not cause severe functional impairment and does not include psychotic features. It often feels good — increased energy, productivity, confidence, reduced need for sleep, faster thinking, increased talkativeness. The problem: hypomania is often followed by a depressive episode, and over time, cycles tend to destabilize.
People with Bipolar II almost never seek treatment during hypomanic episodes — they seek treatment when depressed. Without actively asking about past periods of elevated mood, reduced sleep, and increased activity, the hypomanic episodes are never reported, and the diagnosis remains unipolar depression. A careful longitudinal psychiatric history is essential.
Mood stabilizers — particularly lamotrigine (Lamictal) for Bipolar II, which has strong evidence for depressive episodes — form the foundation of treatment. Quetiapine (Seroquel) is FDA-approved for Bipolar II depression. Lithium remains effective for some patients. Antidepressants alone are generally avoided or used cautiously. Psychoeducation and therapy (particularly CBT adapted for bipolar) are essential alongside medication.